ライフサイエンスコーパス: there was no

1 There was no apparent interaction between Px and Iso treatmen

2 There was no association between liver stiffness and any pati

3 Moreover, there was no association between unit policies and prolongati

4 There was no association with ART initiation in the hospital

5 There was no association with cognition, language or behaviou

6 active surveillance was not statistically significant, and there was no association with upgrading in surveillance biops

7 t at KT and showed the greatest increase in height, whereas there was no catch-up growth in children transplanted >12.

8 There was no change in IGF-1 level from before to after surge

9 When additional organisms were identified by mNGS, there was no change in management in the majority of cases.

10 However, there was no consensus on the relevance of REA, including how

11 There was no correlation between activity and PROMs, but a st

12 There was no difference between the two interventions on the

13 mice was decreased; however, mice were not neutropenic, and there was no difference in absolute blood neutrophils between

14 There was no difference in adverse events between randomised

15 There was no difference in insulin or insulin resistance betw

16 Similarly, there was no difference in patient survival at 1 (94% versus

17 There was no difference in risk of 90-day mortality between b

18 ean titers than mothers of KSHV-positive children; however, there was no difference in the presence of neutralizing antib

19 There was no discordance when all the echocardiographic param

20 Similarly, there was no dose-dependent relationship between PPS exposure

21 For primary outcomes, there was no effect of any UBL intervention compared to contr

22 There was no evidence for associations of physical activity w

23 There was no evidence for increased risks of prostate or colo

24 In the intention-to-treat analysis, there was no evidence of a difference in the proportion of pa

25 There was no evidence of interaction between MRD status and c

26 There was no evidence of large reductions in SFA, but we are

27 There was no evidence that concussion or vision symptom traje

28 earlier and had no medical history of note; in particular, there was no history of cancer or predisposing factors for ch

29 io, 1.15; 95% confidence interval, 1.06, 1.24); conversely, there was no increased risk in women with dental caries and t

30 There was no masking in this open-label trial.

31 25 h shifts (predicted probability 99.4% vs 78.8%), whereas there was no relevant difference between the beginning and en

32 In multivariable adjusted analyses, there was no significant association between baseline eGFR <6

33 There was no significant association between donor MDRO and e

34 There was no significant association between the duration of

35 There was no significant change in LOS or discharge home rate

36 re significantly lower in IUGR than control foetuses, while there was no significant difference among IUGR groups.

37 There was no significant difference between the erythropoieti

38 iated with improvement of these energetic changes such that there was no significant difference in comparison with contro

39 l including the 47 participants completing >=1 diet period, there was no significant difference in DAS28-ESR between the

40 There was no significant difference in patients' satisfaction

41 cute health care use and modestly lower symptom burden, but there was no significant difference in quality of life.

42 There was no significant difference in rate of death by suici

43 But there was no significant difference in the expression of IL-1

44 ophrenia with large effect sizes (Cohen's d = 0.8-0.9), but there was no significant difference in the hippocampus.

45 Within the limitations of this interim analysis, there was no significant difference in treatment time, satisf

46 Similarly, there was no significant difference within different types of

47 There was no statistically significant difference in readmiss

48 There was no statistically significant difference in the inci

49 all-cause mortality (HR, 0.83 [95% CI, 0.75-0.92]), whereas there was no statistically significant mortality reduction wi

50 There was no toxic mortality.